Medizinische Universität Graz - Research portal

Go directly to the nagivation.
Go directly to the content.

Print view.
German.
Contact.
Data entry.
Start.
Open Access.

Navigation/Search

Researchers.
Institutions.
Projects.
Publications.
Partners.
Sponsors.
Equipment.
Knowhow.
Fields of Research.

Selected Publication:

Gnant, M; Jakesz, R; Mlineritsch, B; Luschin-Ebengreuth, G; Schmid, M; Menzel, C; Kubista, E; Samonigg, H; Hausmaninger, H.
Zoledronic acid effectively counteracts cancer treatment induced bone loss (CTIBL) in premenopausal breast cancer patients receiving adjuvant endocrine treatment with goserelin plus anastrozole versus goserelin plus tamoxifen - bone density subprotocol results of a randomized multicenter trial (ABCSG-12)
BREAST CANCER RES TREAT. 2004; 88: S8-S9.
Web of Science

Authors Med Uni Graz:: Luschin-Ebengreuth Gero; Samonigg Hellmut
Altmetrics: